Explore

TrendlineTrendline
Alloop Unveils Trio Wearable with Modular Design and Voice-Enabled AI Health Agent

Alloop Unveils Trio Wearable with Modular Design and Voice-Enabled AI Health Agent

Alloop Unveils Trio Wearable with Modular Design and Voice-Enabled AI Health Agent
TrendlineTrendline
Open Vital App Leverages Wearable Data for Personalized Recovery and Sleep Analysis

Open Vital App Leverages Wearable Data for Personalized Recovery and Sleep Analysis

Open Vital App Leverages Wearable Data for Personalized Recovery and Sleep Analysis
Rapid ReadRapid Read
AutoMynd Introduces AI Assistant for Home Health Clinical Managers to Expedite Patient Chart Review

AutoMynd Introduces AI Assistant for Home Health Clinical Managers to Expedite Patient Chart Review

AutoMynd has launched a patient-level AI assistant designed to assist home health clinical managers in quickly accessing critical patient information from electronic medical records (EMRs). This AI assistant, integrated within AutoMynd's Patient360 view, aims to reduce the time spent sifting through numerous tabs of patient data, such as visit notes, vitals, medication logs, and care plans. Clinical managers can ask natural language questions like 'What changed since the last nursing visit?' or 'Is the patient still homebound with a skilled need?' and receive immediate, sourced answers directly from the patient's chart. The system provides citations for every piece of information, allowing clinicians to verify details before making decisions. This tool is intended to support clinical judgment, not replace it, by providing rapid access to comprehensive patient data for case conferences, recertifications, and physician calls.
Rapid ReadRapid Read
U.S. Mental Health App Market Projected to Reach $5.08 Billion by 2034 Amidst Rising Demand

U.S. Mental Health App Market Projected to Reach $5.08 Billion by 2034 Amidst Rising Demand

The mental health app market in the United States is forecast to experience significant growth, with projections indicating it will reach $5.08 billion by 2034. This growth represents an 8.8% Compound Annual Growth Rate (CAGR) between 2024 and 2034, making the U.S. the strongest country-level growth market globally. The overall global mental health app market is expected to nearly double from $7.19 billion in 2024 to $14.72 billion by 2034. This expansion is attributed to increased awareness of mental well-being, the prevalence of stressful lifestyles, and the growing adoption of mobile health applications. iOS-based applications are currently leading the market, valued at $4.08 billion in 2024, and are projected to reach $8.36 billion by 2034. Key application categories include depression and anxiety management, stress management, meditation, and general wellness, with depression and anxiety management alone expected to grow to $5.83 billion by 2034.
TrendlineTrendline
Wi-Fi Sensing Market Projected to Reach $8.4 Billion by 2034, Driven by Camera-Free Monitoring Demand

Wi-Fi Sensing Market Projected to Reach $8.4 Billion by 2034, Driven by Camera-Free Monitoring Demand

Wi-Fi Sensing Market Projected to Reach $8.4 Billion by 2034, Driven by Camera-Free Monitoring Demand
Rapid ReadRapid Read
Researchers Introduce CHARS to Improve Evaluation of Healthcare Chatbot Quality

Researchers Introduce CHARS to Improve Evaluation of Healthcare Chatbot Quality

Researchers at SRHIN have developed a new tool called CHARS (Chatbot Rating Scale) to assess the quality of health and social care chatbots. This initiative addresses the growing need for a comprehensive evaluation method as AI-powered tools become more common in healthcare. CHARS examines chatbot quality across three key dimensions: Design, Interactive User Experience, and Functionality. The 'Design' dimension evaluates the chatbot's visual presentation and ease of interaction. 'Interactive User Experience' focuses on usability, engagement, and personalization. 'Functionality' assesses whether the chatbot performs its intended tasks effectively. The development of CHARS involved reviewing existing studies and gathering expert insights to create a practical instrument for consistent chatbot quality assessment, moving beyond superficial aspects like engaging conversations or attractive designs.
Rapid ReadRapid Read
University of Cincinnati Hosts Summit on AI's Role in Reshaping Healthcare and Lowering Costs

University of Cincinnati Hosts Summit on AI's Role in Reshaping Healthcare and Lowering Costs

Professionals in artificial intelligence and healthcare recently convened at the University of Cincinnati for a summit focused on how AI can transform medicine, from disease diagnosis to reducing patient costs. The event addressed the rising healthcare expenses, with a national survey by Marsh McLennan indicating an 8% average increase in employer-sponsored health plan costs for the coming year, the highest since 2003. Summit organizer Jamison DeAngelis expressed optimism that AI could enhance the efficiency of healthcare systems, ultimately leading to lower patient costs. Dr. Kelly Kohen, director of the AI Biolab Digital Futures at the University of Cincinnati, highlighted AI's potential to deliver personalized treatment tailored to individual needs. Dr. Alex Tobin, a radiologist, emphasized AI's capability to meticulously analyze medical images, potentially identifying patterns that could predict optimal therapies or patient outcomes. Kyle Frye, CEO of Cortex AI, noted that AI tools could also assist in...
Rapid ReadRapid Read
Americans Show Increased Comfort with AI in Medicine, Emphasizing Provider Oversight

Americans Show Increased Comfort with AI in Medicine, Emphasizing Provider Oversight

A recent Gallup survey indicates that Americans are becoming more comfortable with the use of Artificial Intelligence (AI) in medical decisions, provided there is human oversight. The survey, which included over 5,000 U.S. adults, found that 56% of respondents who had seen a healthcare provider in the past year were somewhat or very comfortable with AI making diagnosis and treatment decisions, as long as a provider could override them. Only 9% were comfortable with AI making decisions without provider review. Similar sentiments were observed for AI in medical imaging review (53% comfortable with oversight) and medication decisions (49% comfortable with oversight). A separate survey of over 1,000 licensed primary care physicians revealed that doctors underestimated patient comfort levels with AI involvement. Despite this, AI use among healthcare providers is growing, with 89% reporting using an AI tool or chatbot in the past year for tasks such as gathering medication information, reviewing patient data, an...
Rapid ReadRapid Read
American Institutes for Research Launches 'AI in Health Network' to Study AI's Impact on Healthcare

American Institutes for Research Launches 'AI in Health Network' to Study AI's Impact on Healthcare

The American Institutes for Research (AIR) has initiated the 'AI in Health Network,' a collaborative research effort aimed at examining how artificial intelligence can enhance healthcare delivery, broaden access to services, and foster improved health outcomes. This network unites researchers, healthcare organizations, and technology developers globally through eight distinct projects. These projects will investigate AI applications within real-world healthcare environments, generating evidence to guide decisions regarding their implementation. The selected initiatives address a diverse array of health challenges, including advancements in cancer treatment, reduction of emergency department wait times, and expansion of access to vision care, HIV prevention, and nutrition services. The network's focus is on producing practical findings that can be utilized by healthcare providers, public health organizations, and policymakers. Brandy Farrar, an AIR Institute Fellow and lead of the AI in Health Network, emph...
Rapid ReadRapid Read
Dr. Kyle Karches Discusses AI's Role and Ethical Implications in Medicine

Dr. Kyle Karches Discusses AI's Role and Ethical Implications in Medicine

Dr. Kyle Karches, a physician and professor of internal medicine at Saint Louis University, is exploring the evolving role of artificial intelligence (AI) in medicine. Dr. Karches, who also teaches healthcare ethics, has been researching AI in medicine since 2018. He notes that AI tools could significantly assist physicians and researchers by enabling rapid access and processing of vast amounts of data, benefiting individual patients and public health. However, he also raises concerns about the potential for dehumanization in a field that inherently deals with the fragility of human life. The discussion, featured on the Jesuit Media Lab's podcast 'AMDG,' delves into whether chatbots could effectively replace doctors in diagnosis and treatment, and the broader implications of AI's rapid advancement on medical practice and education. Saint Louis University is one of four Jesuit medical schools in the U.S.
TrendlineTrendline
The Cigna Group Leverages AI for Enhanced Personalized Healthcare Experience

The Cigna Group Leverages AI for Enhanced Personalized Healthcare Experience

The Cigna Group Leverages AI for Enhanced Personalized Healthcare Experience
Rapid ReadRapid Read
AI Transforms Clinical Trial Management with Focus on Optimization and Patient Recruitment

AI Transforms Clinical Trial Management with Focus on Optimization and Patient Recruitment

Artificial intelligence is increasingly being integrated into clinical trials to enhance various stages, from initial planning to data management. AI tools are designed to optimize study protocols, thereby reducing the need for amendments and accelerating the patient recruitment process. Specialized AI-driven platforms are emerging for patient recruitment, utilizing predictive analytics and natural language processing to identify, stratify, and retain participants more effectively. Furthermore, AI is being applied to automate clinical data monitoring, detect anomalies, and provide deeper insights into trial data. Key players in this evolving market include Medidata Solutions and Oracle Corporation for planning and design, Veeva Systems and Clinerion for patient recruitment, Saama Technologies for data management, and IBM Corporation for monitoring and oversight. These companies are developing distinct AI solutions tailored to specific phases of the clinical trial lifecycle, reflecting the diverse needs for...